Clinical Trial Update: Randomized Trial of Aspirin and Cataracts in U.S. Physicians [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating aspirin for cataract development in U.S. physicians was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Cataract | Phase 3 | Status: TERMINATED